Immix Biopharma
IPOImmix Biopharma is a biotech company in Los Angeles, United States, founded in 2017. It has raised $9.1M across 1 round, most recently a $9.1M Series C in September 2025.
Home - IMMIX BIOPHARMA INC
- Headquarters
- Los Angeles, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- immixbio.com
- Total Funding
- $9.1M
- Last Round
- $9.1M Series CSep 2025
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
Clinical-stage biopharmaceutical company pioneering cell therapies for AL Amyloidosis and other serious diseases.
Summary
It lists 11–50 employees. It has raised $9.1M in total across 1 round, most recently a $9.1M Series C round in Sep 2025. Investors include Morgan Stanley and Goose Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Sign up to see all 2 events
Funding: Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immix-biopharma"><img src="https://indexed.vc/api/badge/company/immix-biopharma" alt="Immix Biopharma on Indexed.vc" width="260" height="76" /></a>